Skip to main content

Table 3 Significantly dysregulated pathways

From: Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis

 

Pathway

Overlap size

p-value (FDR = 5%)

MPS IIIA

Vitamin B1 (thiamin) metabolism

2

2.77E−03

Pyrimidine metabolism

2

9.86E−03

MPS IIIB

TCA cycle

2

1.41E−03

Aspartate and asparagine metabolism

4

1.81E−03

Vitamin E metabolism

3

3.00E−03

Methionine and cysteine metabolism

3

4.78E−03

Fatty acid activation

2

4.89E−03

Lysine metabolism

2

9.66E−03

De novo fatty acid biosynthesis

2

1.31E−02

Tryptophan metabolism

3

3.31E−02

MPS IIIC

Vitamin B1 (thiamin) metabolism

2

5.54E−04

Omega-3 fatty acid metabolism

2

8.27E−04

Butanoate metabolism

2

1.71E−03

Tryptophan metabolism

3

8.07E−03

Linoleate metabolism

2

1.18E−02

Tyrosine metabolism

3

2.28E−02

Methionine and cysteine metabolism

2

2.60E−02

MPS IIID

TCA cycle

2

1.41E−03

Vitamin B1 (thiamin) metabolism

2

1.41E−03

Aspartate and asparagine metabolism

4

3.08E−03

Butanoate metabolism

2

5.14E−03

Carnitine shuttle

2

2.32E−02

Arginine–proline metabolism

2

2.91E−02

Tryptophan metabolism

3

4.36E−02

  1. FDR false discovery rate